MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
978.81%
Quick Ratio
978.81%
Cash Ratio
98.40%
Debt to Asset Ratio
11.04%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Noncontrolling interest (note 2)
    • Others

Balance Sheets
2026-04-30
2026-01-31
2025-10-31
2025-07-31
Cash and cash equivalents
1,477 1,547 1,244 1,495
Short-term investments
12,209 12,655 13,930 14,534
Receivables
56 NaN NaN 0
Prepaid expenses and other current assets
950 848 713 1,420
Total current assets
14,692 15,050 15,887 17,449
Operating lease right-of-use asset
173 183 193 202
Total assets
14,865 15,233 16,080 17,651
Accounts payable
252 148 165 276
Accrued expenses
1,205 1,046 1,761 1,751
Operating lease liability
44 42 41 39
Total current liabilities
1,501 1,236 1,967 2,066
Operating lease liability, non-current
140 151 163 174
Total liabilities
1,641 1,387 2,130 2,240
Preferred stock, value
NaN NaN NaN 0
Preferred stock, value-Series AConvertible Preferred Stock
NaN NaN NaN 0
Treasury stock, 2,000 shares at cost as of october 31, 2024
NaN NaN NaN 0
Common stock, par value .01 per share 100,000,000 shares authorized 33,922,776 and 33,013,829 shares issued and outstanding as of april 30, 2026 and october 31, 2025, respectively
339 335 330 328
Additional paid-in capital
270,894 268,984 266,508 265,249
Accumulated deficit
-256,758 -254,242 -251,677 -248,982
Total shareholders equity
14,475 15,077 15,161 16,595
Noncontrolling interest (note 2)
-1,251 -1,231 -1,211 -1,184
Total equity
13,224 13,846 13,950 15,411
Total liabilities and equity
14,865 15,233 16,080 17,651
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$12,209K Cash and cashequivalents$1,477K Prepaid expenses andother current assets$950K Receivables$56K Total current assets$14,692K Operating leaseright-of-use asset$173K Total assets$14,865K Total liabilities andequity$14,865K Total equity$13,224K Total liabilities$1,641K Noncontrolling interest (note2)-$1,251K Total shareholdersequity$14,475K Total currentliabilities$1,501K Operating leaseliability, non-current$140K Accumulated deficit-$256,758K Additional paid-in capital$270,894K Accrued expenses$1,205K Accounts payable$252K Operating lease liability$44K Common stock, par value.01 per share...$339K

Anixa Biosciences Inc (ANIX)

Anixa Biosciences Inc (ANIX)